Get the Stockscreener App
1.84
0.00%
0.00
Pre-market:
1.88
0.04
+2.17%
Stereotaxis Inc stock is traded at $1.84, with a volume of 262.19K.
It is up +0.00% in the last 24 hours and down -0.54% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$1.84
Open:
$1.88
24h Volume:
262.19K
Relative Volume:
0.69
Market Cap:
$179.84M
Revenue:
$32.38M
Net Income/Loss:
$-21.64M
P/E Ratio:
-7.3103
EPS:
-0.2517
Net Cash Flow:
$-13.78M
1W Performance:
+1.66%
1M Performance:
-0.54%
6M Performance:
-20.69%
1Y Performance:
-12.80%
1-Day Range:
$1.83
$1.92
1-Week Range:
$1.75
$1.92
52-Week Range:
$1.70
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
1.84 | 179.84M | 32.38M | -21.64M | -13.78M | -0.2517 |
ISRG
Intuitive Surgical Inc
|
416.55 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.52 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.29 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.33 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
192.74 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Stereotaxis eyes billions in market opportunity with Robocath takeover - MSN
Stereotaxis (STXS) Stock Price, News & Analysis $STXS - MarketBeat
Stereotaxis Inc (NYSE: STXS) Share Price, STXS Stock News, STXS Share Price & Updates - Kalkine
Stereotaxis, Inc. cites 500 peer-reviewed publications on robotic electrophysiology safety and efficacy - Traders Union
Stereotaxis, Inc. unveils remote access technology in cardiology test drive event - Traders Union
Citizens reiterates Stereotaxis stock rating on growth outlook By Investing.com - Investing.com South Africa
Citizens reiterates Stereotaxis stock rating on growth outlook - Investing.com
STXS Q1 2026 Earnings: Wider-than-Expected Loss Amidst Revenue ChallengesFree Cash Flow Trends - newsline.com
STXS Q1 2026 Earnings: EPS Misses Estimates as Losses WidenEarnings Trend Analysis - newsline.com
Stereotaxis Inc. (STXS) Slips 4.8% – Testing Key Support at $1.88TPO Profile - The Legal Advocate
Stereotaxis Inc. (STXS) Faces Selling Pressure as Shares Slide to $1.98Ratio Spread Trade - The Legal Advocate
Stereotaxis, Inc. advances robotic precision to transform patient care - Traders Union
Stereotaxis stock up on first US MAGIC procedures post approval - MSN
Stereotaxis Inches Upwards as Shares Approach Resistance at $2.02KAMA Signal - The Legal Advocate
Stereotaxis (STXS) Edges Higher: Navigating the Robotics Sector with Modest GainsVolatility Term Structure - Newser
Stereotaxis Emerges as Notable Oversold Play in AI Sector with Over 120 Percent Implied Upside - HarianBasis.co
Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why - Insider Monkey
Stereotaxis Inc. (STXS) Edges Higher as Stock Tests Key Resistance Near $2.02Shared Buy Zones - Newser
STXS Q1 2026 Earnings: Larger-Than-Expected Loss as Company Continues Strategic TransitionROA Comparison - Newser
5 Most Oversold AI Stocks to Buy According to Analysts - Insider Monkey
Stereotaxis Q1 earnings call highlights - MSN
Stereotaxis to acquire Robocath for up to $45M - MSN
Stereotaxis Q1 Earnings Call Highlights - TradingView
Stereotaxis shareholders elect directors and approve key proposals at annual meeting - Investing.com India
Stereotaxis, Inc. touts robotic technology to address physician burnout and improve patient care - Traders Union
Lagoda Investment discloses 4.5% stake in Stereotaxis (STXS) - Stock Titan
Stereotaxis Q4 Loss Narrows, Revenue Rises - Moomoo
Stereotaxis (NYSE: STXS) holders back board, auditor and executive pay - Stock Titan
Stereotaxis Inc. (STXS) reports Q1 loss, lags revenue estimates - MSN
Stereotaxis reports early traction for new products as Robocath acquisition advances - The Business Journals
Stereotaxis, Inc. 1Q 2026: Revenue $6.29M, EPS $(0.06) — 10-Q Summary - TradingView
Stereotaxis (STXS) posts Q1 2026 loss and plans $20M Robocath acquisition - Stock Titan
STXS Reiterated by Piper Sandler -- Price Target Lowered to $3.5 - GuruFocus
Lake Street Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Stereotaxis, Inc. (AMEX:STXS) Q1 2026 Earnings Call Transcript - Insider Monkey
Stereotaxis expects annual revenue to surpass $40M with Q3 and Q4 above $10M as MAGiC and Synchrony ramp - MSN
Stereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigat - GuruFocus
Stereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigating Regulatory Wins and Revenue ... By GuruFocus - Investing.com Canada
Stereotaxis, Inc. (STXS) Reports Strong Q1 2026 Earnings and Gro - GuruFocus
Earnings call transcript: Stereotaxis Q1 2026 misses forecasts, stock dips - Investing.com India
Is Stereotaxis (STXS) Still 23.2% Undervalued After Q1 2026? EPS - GuruFocus
STXS: Regulatory wins and new product launches drive optimism for double-digit revenue growth in 2026 - TradingView
Earnings call transcript: Stereotaxis Q1 2026 misses forecasts, stock dips By Investing.com - Investing.com Nigeria
STXS: Transition to new robotic and catheter platforms drives optimism for double-digit growth in 2026 - TradingView
Stereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Stereotaxis Q1 2026 Earnings Call Transcript - Benzinga
Stereotaxis Inc (NYSEARCA:STXS) Slides 6% After Q1 Revenue Miss Despite Narrower-Than-Expected Loss - ChartMill
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
1.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):